Oxaliplatin in Treating Patients With Liver Cancer

Summary

Phase II trial to study the effectiveness of oxaliplatin in treating patients who have unresectable, recurrent or metastatic liver cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start

2002-09

Primary completion

2006-01

Completion

—

Drugs

Indications